Personalised reimbursement: A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients

Authors :: L.R. Hoes
S B van Waalwijk van Doorn-Khosrovani
Stefan Sleijfer
Henk M.W. Verheul
W.H. van Harten
H. van der Wijngaart
A. D. R. Huitema
Emile E. Voest
J.M. van Berge Henegouwen
L. Timmers
M van der Graaff
J Gijzen
D.L. van der Velden
A. Pisters-van Roy
E. van Werkhoven
L. van Saase
Valesca P. Retèl
Hans Gelderblom
Health Technology & Services Research
Medical Oncology
Source :: Annals of oncology, 30(5), 663-665. Oxford University Press, Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 30(5), 663. Oxford University Press, Annals of Oncology, 30(5), 663-665, Annals of Oncology, 30, 663-665, Annals of Oncology, 30(5), 663-665. Elsevier Ltd., van Waalwijk van Doorn-Khosrovani, S B, Pisters-van Roy, A, van Saase, L, van der Graaff, M, Gijzen, J, Sleijfer, S, Hoes, L R, van Berge Henegouwen, J M, van der Wijngaart, H, van der Velden, D L, van Werkhoven, E, Retel, V P, van Harten, W H, Huitema, A D R, Timmers, L, Gelderblom, H, Verheul, H M W & Voest, E E 2019, ' Personalised reimbursement: A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients ', Annals of Oncology, vol. 30, no. 5, pp. 663-665 . https://doi.org/10.1093/annonc/mdz119, Annals of Oncology, 30, 5, pp. 663-665
Publication Year :: 2019
Abstract: Contains fulltext : 207396.pdf (Publisher’s version ) (Open Access)

Language :: English
ISSN :: 09237534
Database :: OpenAIRE
Journal :: Annals of oncology, 30(5), 663-665. Oxford University Press, Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 30(5), 663. Oxford University Press, Annals of Oncology, 30(5), 663-665, Annals of Oncology, 30, 663-665, Annals of Oncology, 30(5), 663-665. Elsevier Ltd., van Waalwijk van Doorn-Khosrovani, S B, Pisters-van Roy, A, van Saase, L, van der Graaff, M, Gijzen, J, Sleijfer, S, Hoes, L R, van Berge Henegouwen, J M, van der Wijngaart, H, van der Velden, D L, van Werkhoven, E, Retel, V P, van Harten, W H, Huitema, A D R, Timmers, L, Gelderblom, H, Verheul, H M W & Voest, E E 2019, ' Personalised reimbursement: A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients ', Annals of Oncology, vol. 30, no. 5, pp. 663-665 . https://doi.org/10.1093/annonc/mdz119, Annals of Oncology, 30, 5, pp. 663-665
Accession number :: edsair.doi.dedup.....14bb10cc3af9d34cae84a7503cc0401d
Full Text :: https://doi.org/10.1093/annonc/mdz119

Full Text Access

Tools